Persistent High Fever After Metchloropramide Treatment; Neuroleptic Malignant Syndrome

Introduction: Neuroleptic Malignant Syndrome(NMS) is a state neurotransmitter levels fluctuate subsequent to administration of neuroleptic agents. Etiology of NMS is unclear. It’s a neurological emergency includes symptoms like altered mental status, rigidity, fever and dysautonomy. Our aim in here is to mention the side effects of metochlopramide, which is commonly used in Emergency Departments(ED). In our case, subsequent to intravenous admission of metochlopramide, patients clinic worsened with NMS symptoms and this was quite unexpected and unwanted for ED doctors. By this case report it is wanted to raise awareness against, side effects of metoclopramide and NMS. Case Report: Subsequent to intravenous administration of single dose metoclopramide to relieve abdominal pain into 21 years old male with no history of chronical diseases, symptoms of fever, muscle rigidity, confusion and fluctuating blood pressure levels quickly emerged along with leukocytosis and high levels of Creatine Kinase. ED Doctors suspected NMS. Futher laboratory and imaging stuides has excluded other central nervous system pathologies and infections. Eventually, patients clinic got better with symptomatic theraphy and he was discharged fully recovered. Conclusion: NMS due to metoclopramide is quite rare, but usage of therapies includes Metoclopramid at ED’s are quite often. Subsequent to administration of this drug, if patients clinical state worsens with fever, confusion and muscle rigidity, phycisians should keep NMS in mind.

Keywords:

Advers reactions metoclopramide, Neuroleptic Malignant Syndrome,

PDF

___

Neuroleptic Malignant Syndrome - UpToDate [Internet]. [cited 2022 Feb 15]. Available from: https://www.uptodate.com/contents/neuroleptic-malignant-syndrome?search=n%C3%B6roleptik%20malign&source=search_result&selectedTitle=1~68&usage_type=default&display_rank=1.
Strawn JR, Keck PE, Caroff SN. Neuroleptic malignant syndrome. American Journal of Psychiatry 2007;164(6):870–6.
Doğan N, Kürşad H, Fuat A, Kızılkaya M. Nöroleptik Malign Sendromda Nadir Etyolojik Faktörler ve Klinik Seyir Rare Etıologıc Factors And Clınıcal Process Of Neuroleptıc Malıgnant Syndrome. MJAU 2003; 35: 23-26.
Neuroleptic Malignant Syndrome - StatPearls - NCBI Bookshelf [Internet]. [cited 2022 Feb 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482282/?report=classic.
Neuroleptic Malignant Syndrome - ClinicalKey [Internet]. [cited 2022 Feb 15]. Available from: https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323755702006354?scrollTo=%23hl0000317.
Simon LV, Hashmi MF, Callahan AL. Neuroleptic Malignant Syndrome. StatPearls [Internet]. 2021 Sep 19 [cited 2022 Feb 15]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK482282/.
Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome: An easily overlooked neurologic emergency. Neuropsychiatric Disease and Treatment 2017 Jan 16;13:161–75.
Çeviker SA, Yıldız E, Yılmaz M. Metoklopramid Kullanımı Sonrası Gelişen Malign Nöroleptik Sendrom: Olgu Sunumu. IGUSABDER [Internet]. 2020 [cited 2022 Feb 17];10:123–9. Available from: https://orcid.org/0000-0001-6874.
Ware MR, Feller DB, Hall KL. Neuroleptic Malignant Syndrome: Diagnosis and Management. The Primary Care Companion for CNS Disorders [Internet]. 2018 Jan 4 [cited 2022 Feb 17];20(1):27030. Available from: https://www.psychiatrist.com/pcc/effects/neuroleptic-malignant-syndrome/neuroleptic-malignant-syndrome.